Back to Search
Start Over
European Medicines Agency COMP Recommends Positive Opinion on Orphan Medicinal Product Designation for NUZYRA(R) (omadacycline) for Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
- Source :
- GlobeNewswire. June 27, 2023
- Publication Year :
- 2023
-
Abstract
- BOSTON, June 27, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.754819438